Lexington Announces First Multicenter Clinical Study Site
August 21, 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Biosciences Receives HeartSentry USPTO Patent Approval
July 25, 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 25, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Biosciences Announces Results of Annual General Meeting
July 02, 2018 19:32 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, July 02, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, wishes...
Lexington Biosciences Concludes Initial HeartSentry Clinical Study
June 27, 2018 08:30 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, June 27, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Biosciences Announces Amended Terms to Previously Announced Brokered Financing
June 11, 2018 07:45 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, British Columbia, June 11,...
Lexington Engages with Major Canadian University and Provides Clinical Trial Update
May 08, 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, May 08, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Announces Brokered Private Placement
May 04, 2018 07:00 ET
|
Lexington Biosciences, Inc.
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN VANCOUVER, B.C., May 04, 2018 (GLOBE...
Lexington Releases Audited Consolidated Financial Statements
April 30, 2018 20:18 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, April 30, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, has...
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
March 05, 2018 03:05 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Begins HeartSentry Clinical Trial
February 20, 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Feb. 20, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...